Literature DB >> 10441176

Natural anti-endothelial cell antibodies (AECA).

N Ronda1, S Leonardi, G Orlandini, R Gatti, S Bellosta, F Bernini, A Borghetti.   

Abstract

Natural AECA constitute a pool of autoantibodies circulating in healthy subjects, which react with a restricted and conserved set of endothelial antigens and establish idiotypic interactions within the immunoglobulin networks. Normal IgG interacts with living endothelial cells and is internalized with a mechanism involving microtubules and resembling that of ligand-receptor internalization. IgG-endothelial cell interaction appears to be dependent on the variable region of antibodies and is followed by modifications of endothelial cell function. Natural AECA increase anti-inflammatory properties of endothelial cells through the selective inhibition of thromboxane A2, endothelin and metalloproteinase-9 secretion, and also through the inhibition of endothelial cell proinflammatory response to TNF-alpha. We have gathered evidence demonstrating that natural AECA constitute a strictly controlled autoantibody pool, interact with living endothelial cells and take part in the regulation of endothelial function, through direct anti-inflammatory effects. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10441176     DOI: 10.1016/s0896-8411(99)99999-7

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  11 in total

Review 1.  Facing the enigma of immunomodulatory effects of intravenous immunoglobulin.

Authors:  Tal Sapir; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2005-12       Impact factor: 8.667

2.  Existence of circulating anti-endothelial cell antibodies after heart transplantation is associated with post-transplant acute allograft rejection.

Authors:  Karla Lehle; Johannes Kroher; Philipp Kolat; Marietta von Süßkind-Schwendi; Christof Schmid; Assad Haneya; Leopold Rupprecht; Stephan Hirt
Journal:  Heart Vessels       Date:  2015-03-28       Impact factor: 2.037

3.  Normal human IgG prevents endothelial cell activation induced by TNFalpha and oxidized low-density lipoprotein atherogenic stimuli.

Authors:  N Ronda; F Bernini; R Giacosa; R Gatti; N Baldini; C Buzio; G Orlandini
Journal:  Clin Exp Immunol       Date:  2003-08       Impact factor: 4.330

Review 4.  Antiendothelial cells autoantibodies in vasculitis-associated systemic diseases.

Authors:  Philippe Guilpain; Luc Mouthon
Journal:  Clin Rev Allergy Immunol       Date:  2008-10       Impact factor: 8.667

5.  Anti-endothelial cell antibodies in connective tissue diseases associated with pulmonary arterial hypertension.

Authors:  Xiao-Dan Liu; Sheng-Yu Guo; Li-Li Yang; Xiao-Li Zhang; Wen-Yi Fu; Xiao-Fei Wang
Journal:  J Thorac Dis       Date:  2014-05       Impact factor: 2.895

6.  Identification of target antigens of anti-endothelial cell and anti-vascular smooth muscle cell antibodies in patients with giant cell arteritis: a proteomic approach.

Authors:  Alexis Régent; Hanadi Dib; Kim H Ly; Christian Agard; Mathieu C Tamby; Nicolas Tamas; Babette Weksler; Christian Federici; Cédric Broussard; Loïc Guillevin; Luc Mouthon
Journal:  Arthritis Res Ther       Date:  2011-06-28       Impact factor: 5.156

7.  Immunological evidence and regulatory potential for cell-penetrating antibodies in intravenous immunoglobulin.

Authors:  Aggeliki D Sali; Ioannis Karakasiliotis; Maria Evangelidou; Stratis Avrameas; Peggy Lymberi
Journal:  Clin Transl Immunology       Date:  2015-10-02

8.  In vitro and in vivo properties differ among liquid intravenous immunoglobulin preparations.

Authors:  F Dhainaut; P-O Guillaumat; H Dib; G Perret; A Sauger; C de Coupade; M Beaudet; M Elzaabi; L Mouthon
Journal:  Vox Sang       Date:  2012-09-25       Impact factor: 2.144

Review 9.  An innovative method to identify autoantigens expressed on the endothelial cell surface: serological identification system for autoantigens using a retroviral vector and flow cytometry (SARF).

Authors:  Tsuyoshi Shirai; Hiroshi Fujii; Masao Ono; Ryu Watanabe; Tomonori Ishii; Hideo Harigae
Journal:  Clin Dev Immunol       Date:  2013-01-16

Review 10.  Antiphospholipid antibodies: paradigm in transition.

Authors:  Lawrence L Horstman; Wenche Jy; Carlos J Bidot; Yeon S Ahn; Roger E Kelley; Robert Zivadinov; Amir H Maghzi; Masoud Etemadifar; Seyed Ali Mousavi; Alireza Minagar
Journal:  J Neuroinflammation       Date:  2009-01-20       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.